Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study

被引：0
|
作者：
Jaymin B. Morjaria
Alan Rigby
Alyn H. Morice
机构：
[1] Hull York Medical School,Centre for Cardiovascular & Metabolic Research
[2] University of Hull,Department of Respiratory Medicine
[3] Castle Hill Hospital,undefined
[4] Royal Brompton & Harefield NHS Trust,undefined
[5] Harefield Hospital,undefined
来源：
Lung | 2017年 / 195卷
关键词：
Fluticasone; Inhaled corticosteroids; Tiotropium; UPLIFT; Pneumonia; COPD;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：281 / 288
页数：7
相关论文
共 50 条
  • [1] Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study
    Morjaria, Jaymin B.
    Rigby, Alan
    Morice, Alyn H.
    LUNG, 2017, 195 (03) : 281 - 288
  • [2] Risk of pneumonia and exacerbations of chronic obstructive pulmonary disease(COPD) with inhaled corticosteroid (ICS) use: a Singapore perspective
    Koh, Kenneth
    Tiew, Pei Yee
    Tan, Jessica Han Ying
    Soh, Rui Ya
    Tan, Karen Li Leng
    Ong, Thun How
    Koh, Mariko Si Yue
    Chotirmall, Sanjay Haresh
    Lapperre, Therese Sophie
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [3] The Relationship among COPD Severity, Inhaled Corticosteroid Use, and the Risk of Pneumonia
    Rennard, Stephen I.
    Sin, Donald D.
    Tashkin, Donald P.
    Calverley, Peter M.
    Radner, Finn
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 (10) : 1587 - 1589
  • [4] Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
    Tashkin, Donald P.
    Miravitlles, Marc
    Celli, Bartolome R.
    Metzdorf, Norbert
    Mueller, Achim
    Halpin, David M. G.
    Anzueto, Antonio
    RESPIRATORY RESEARCH, 2018, 19
  • [5] Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
    Donald P. Tashkin
    Marc Miravitlles
    Bartolomé R. Celli
    Norbert Metzdorf
    Achim Mueller
    David M. G. Halpin
    Antonio Anzueto
    Respiratory Research, 19
  • [6] Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
    Vestbo, Jorgen
    Vogelmeier, Claus F.
    Small, Mark
    Siddall, James
    Fogel, Robert
    Kostikas, Konstantinos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 853 - 861
  • [7] Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia
    Singanayagam, A.
    Chalmers, J. D.
    Akram, A. R.
    Hill, A. T.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (01) : 36 - 41
  • [8] Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
    Calverley, Peter M. A.
    Wouters, Emiel F. M.
    Finnigan, Helen
    Tetzlaff, Kay
    Magnussen, Helgo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [9] Spirometry, Exacerbations, And Bronchodilator Use Among COPD Patients Initiating Inhaled Corticosteroid Therapy
    Munson, J. C.
    Mahler', D. A.
    Smith, J.
    Morden, N. E.
    Skinner, J. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [10] Risk of pneumonia with long-term inhaled corticosteroid use
    Reactions Weekly, 2009, 1244 (1) : 3 - 3
12345